J&J faces new trial over talc cancer claims, amid settlement push

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MGM
7. NVDA
8. MCD
9. GDDY
10. COST

Go back to J&J faces new trial over talc cancer claims, amid settlement push
Johnson & Johnson (NYSE: JNJ) Delayed: 270.68 +1.51 (0.56%)
Previous Close $269.17    52 Week High $126.07 
Open $269.52    52 Week Low $94.28 
Day High $275.23    P/E 56.27 
Day Low $269.01    EPS $4.81 
Volume 6,323,028